This suggests that CTBP1 could be a potential prognostic factor for breast cancer patients with p53 mutations which may be due to the fact that apoptosis induction is more effective on prolonging overall survival of patients than p53-dependent growth arrest. Here, TP53 is linked to breast carcinoma.